HPVC2026-058: Pharmaceutical Products
Current Contract
Contract start date: 30 Jan 2026
Contract end date: 28 Feb 2029
Option periods: 2 x 2yrs
Description
Contract for the provision of a range of pharmaceutical products to Victorian public health services.Additional information
Update: 14 August 2026.
Title: HPVITS2026-058.002 Pharmaceutical Products Supplementary 002
HSV has made an update for Supplementary 002. Please find the updated information as below:
TENDER IS NOW LIVE
- Market Release Date: 14 August 2026
- Market Closing Date: 24 August 2026 14:00 AEST
To access the tender please register for a supplier account: https://healthsharevic.org.au/register/
Contact our helpdesk if you need support at helpdesk@healthsharevic.org.au.
Once your account has been approved, find the tender here:
1. Log into your HSV website account https://healthsharevic.org.au/ - you will land on My Dashboard
2. Select JAGGAER Advantage Procurement Portal from your Quick links
3. The Procurement Portal will load in a new browser window:
4. All open tenders are available from RFX OPEN TO ALL SUPPLIERS in the Main Dashboard
5. Select the numbered link aligned with Currently Open for either an RFQ or RFI
6. You must Express Interest in the tender before you can access the information and documents.
Scope for Supplementary 002:
|
Subcategory Number |
Subcategory Description |
|
34.01 |
APIXABAN 2.5 MG TABLET 20 |
|
34.02 |
APIXABAN 2.5 MG TABLET 30 |
|
34.03 |
APIXABAN 2.5 MG TABLET 60 |
|
34.04 |
APIXABAN 5 MG TABLET 28 |
|
34.05 |
APIXABAN 5 MG TABLET 60 |
Tentative dates:
- Announcement of outcome to suppliers: 21 September 2026
- Announcement of outcome to health services: 1 October 2026
- Contract Commencement Date: 19 October 2026
Useful information:
- To register for a supplier account: https://healthsharevic.org.au/register/, and contact our Helpdesk if you need support at helpdesk@healthsharevic.org.au.
- To subscribe and receive contract update notifications, favourite this contract cabinet.
- Review your account settings to ensure the notification frequency selected is adequate.
Categories
Categories 1 – 4,999 Pharmaceutical productsCategories 5,000 – 5,999 Inhaled gases
Categories 6,000 – 7,999 Prescription biological medicines
Categories 8,000 – 9,000 Therapeutic group products